Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
The role of Mechano-sensitive ion channels in Osteoarthritis pain
FY 2013-14
Summary
Osteoarthritis (OA) is a prevalent and debilitating disease affecting one in six Canadians aged 15 and over. The disease is marked by progressive degeneration of the cartilage, aberrant growth/remodelling of bone and a complex pain phenotype. Sufferers complain of persistent, nagging, dull apin of affected joints, as well as pain in response to joint palpation or movement. Our current understanding of OA pain is that it is the result of inflammatory mediators (cytokines) that accumulate in the affected joints and sensitize pain sensing neurons (nociceptors). The outcome is that these neurons that would normally become activated exclusively by painful stimuli now also activate in response to gentle stimulation such as touch. One prominent cytokine that is elevated in affected OA joints is Tumor Necrosis Factor-alpha (TNF). Many studies have demonstrated that TNF exposure results in increased sensitivity of nociceptors. This cytokine acts the its receptor, located on nociceptors, to induce this mechanical hypersensitivity. However, the mechanisms through which this sensitization occurs remain to be elucidated.
Mechanosensitive ion channels (MSCs) are proteins at the membrane of nociceptors that sense mechanical stresses such as joint palpation and respond by eliciting currents that can generate pain signals. Whether MSCs become sensitized during OA is currently unknown. My preliminary results suggest that this is indeed the case, as MSCs in nociceptors treated with TNF become sensitized. However, the mechanisms that mediate MSC sensitization are still unknown.
My project aims to connect the putative link between pro-inflammatory cytokines and sensitized MSCs. My hypothesis is that TNF acts through its receptor to directly/indirectly sensitize MSCs. This would result in these nociceptors signalling pain for otherwise non-painful physical stimuli, i.e. mechanical hypersensitivity. There are a few ways that TNF can affect MSCs: it may simply increase gene expression of MSCs so that more channels are at the membrane, amplifying the cell's mechanosensitive response. Similarly, internalized MSCs may be targeted to the membrane, resulting once again in response amplification. Lastly, TNF may be increasing the sensitivity of pre-existing MSCs by modulating their coupling with the structural components of the cell, thereby enabling more efficient transduction of force to the channel.
Using electrophysiology, I can record the activity of MSCs at the single channel level in mice nociceptors. I will be able to tease out the differences in MSC function between control- and TNF-treated nociceptors. Moreover, I have several pharmacological compounds I can pre-treat these nociceptors with, such that I can isolate the potential pathways through which TNF may affect MSCs. Taken together, the data from these experiments will help define a clear mechanism by which TNF, a pro-inflammatory cytokine relevant in OA pathology, induces clinically-observed symptoms of mechanical hypersensitivity. Ultimately, the information discovered here can go to support new OA pain therapies and/or reaffirm current anti-TNF therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311859
Name
He Haitian
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of Mechano-sensitive ion channels in Osteoarthritis pain
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Disease Model; Cell Biology; Electrophysiology; Inflammatory Pain; Mechanosensitive Channels; Osteoarthritis; Pain/Hypersensitivity; Tnf-Alpha
Abstract
Osteoarthritis (OA) is a prevalent and debilitating disease affecting one in six Canadians aged 15 and over. The disease is marked by progressive degeneration of the cartilage, aberrant growth/remodelling of bone and a complex pain phenotype. Sufferers complain of persistent, nagging, dull apin of affected joints, as well as pain in response to joint palpation or movement. Our current understanding of OA pain is that it is the result of inflammatory mediators (cytokines) that accumulate in the affected joints and sensitize pain sensing neurons (nociceptors). The outcome is that these neurons that would normally become activated exclusively by painful stimuli now also activate in response to gentle stimulation such as touch. One prominent cytokine that is elevated in affected OA joints is Tumor Necrosis Factor-alpha (TNF). Many studies have demonstrated that TNF exposure results in increased sensitivity of nociceptors. This cytokine acts the its receptor, located on nociceptors, to induce this mechanical hypersensitivity. However, the mechanisms through which this sensitization occurs remain to be elucidated.
Mechanosensitive ion channels (MSCs) are proteins at the membrane of nociceptors that sense mechanical stresses such as joint palpation and respond by eliciting currents that can generate pain signals. Whether MSCs become sensitized during OA is currently unknown. My preliminary results suggest that this is indeed the case, as MSCs in nociceptors treated with TNF become sensitized. However, the mechanisms that mediate MSC sensitization are still unknown.
My project aims to connect the putative link between pro-inflammatory cytokines and sensitized MSCs. My hypothesis is that TNF acts through its receptor to directly/indirectly sensitize MSCs. This would result in these nociceptors signalling pain for otherwise non-painful physical stimuli, i.e. mechanical hypersensitivity. There are a few ways that TNF can affect MSCs: it may simply increase gene expression of MSCs so that more channels are at the membrane, amplifying the cell's mechanosensitive response. Similarly, internalized MSCs may be targeted to the membrane, resulting once again in response amplification. Lastly, TNF may be increasing the sensitivity of pre-existing MSCs by modulating their coupling with the structural components of the cell, thereby enabling more efficient transduction of force to the channel.
Using electrophysiology, I can record the activity of MSCs at the single channel level in mice nociceptors. I will be able to tease out the differences in MSC function between control- and TNF-treated nociceptors. Moreover, I have several pharmacological compounds I can pre-treat these nociceptors with, such that I can isolate the potential pathways through which TNF may affect MSCs. Taken together, the data from these experiments will help define a clear mechanism by which TNF, a pro-inflammatory cytokine relevant in OA pathology, induces clinically-observed symptoms of mechanical hypersensitivity. Ultimately, the information discovered here can go to support new OA pain therapies and/or reaffirm current anti-TNF therapies.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
He, Haitian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~